Portage Biotech Inc. (PRTG)
NASDAQ: PRTG · IEX Real-Time Price · USD
0.540
-0.002 (-0.37%)
At close: Mar 27, 2024, 4:00 PM
0.550
+0.010 (1.85%)
After-hours: Mar 27, 2024, 4:57 PM EDT
Portage Biotech Market Cap
Portage Biotech has a market cap or net worth of $10.68 million as of March 28, 2024. Its market cap has decreased by -79.13% in one year.
Market Cap
10.68M
Enterprise Value
12.95M
1-Year Change
-79.13%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since March 1, 2021, Portage Biotech's market cap has decreased from $410.50M to $10.68M, a decrease of -97.40%. That is a compound annual growth rate of -69.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 10.70M | 1.90% |
Mar 26, 2024 | 10.50M | 9.38% |
Mar 25, 2024 | 9.60M | -3.03% |
Mar 22, 2024 | 9.90M | -11.61% |
Mar 21, 2024 | 11.20M | 25.84% |
Mar 20, 2024 | 8.90M | -18.35% |
Mar 19, 2024 | 10.90M | -4.39% |
Mar 18, 2024 | 11.40M | 4.59% |
Mar 15, 2024 | 10.90M | - |
Mar 14, 2024 | 10.90M | -6.03% |
Mar 13, 2024 | 11.60M | 4.50% |
Mar 12, 2024 | 11.10M | 5.71% |
Mar 11, 2024 | 10.50M | -5.41% |
Mar 8, 2024 | 11.10M | 1.83% |
Mar 7, 2024 | 10.90M | -3.54% |
Mar 6, 2024 | 11.30M | 0.89% |
Mar 5, 2024 | 11.20M | 0.90% |
Mar 4, 2024 | 11.10M | -0.89% |
Mar 1, 2024 | 11.20M | -4.27% |
Feb 29, 2024 | 11.70M | -15.22% |
Feb 28, 2024 | 13.80M | 10.40% |
Feb 27, 2024 | 12.50M | 8.70% |
Feb 26, 2024 | 11.50M | 10.58% |
Feb 23, 2024 | 10.40M | 8.33% |
Feb 22, 2024 | 9.60M | 33.33% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Genetic Technologies | 11.03M |
XORTX Therapeutics | 11.01M |
BioCardia | 10.86M |
Predictive Oncology | 10.85M |
ProSomnus | 10.77M |
Imunon | 10.62M |
Organovo Holdings | 10.54M |
Akari Therapeutics, | 10.52M |